Play
Video

Current Studies

Clinical trials advance medical treatment and therapy to increase survival and quality of life.  

Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.  

Successful treatments we know today are the result of past clinical trials. 

Purpose

The aim of this EAP is to make Daraxonrasib available to eligible patients with pancreatic adenocarcinoma, a serious & life-threatening condition, who have no comparable or satisfactory alternative therapy approved by the FDA.

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at 318-212-8671 .